Increase of Free Insulin-Like Growth Factor-1 in Normal Human Breast in vivo Late in the Menstrual Cycle
- 1 July 2003
- journal article
- Published by Springer Nature in Breast Cancer Research and Treatment
- Vol. 80 (2) , 193-198
- https://doi.org/10.1023/a:1024575103524
Abstract
Prolonged exposure to endogenous and exogenous sex steroids increases the risk of breast cancer but the mechanisms are poorly understood. Increased levels of circulating insulin-like growth factor-1 (IGF-1) and low levels of IGF binding protein are associated with increased risk of breast cancer suggesting that IGF-1 has to be in its free form to be biologically active. Little is known about sex steroid regulation of IGF-1 locally in the breast. In this study microdialysis was used to determine the local levels of free IGF-1 in normal human breast tissue in healthy female volunteers during the menstrual cycle. The results showed that the extracellular levels of free IGF-1 locally in the breast were doubled in the luteal phase, when estradiol and progesterone levels were elevated, compared with the follicular phase. In plasma, free IGF-1 levels also exhibited a cyclic variation but to a less extent. The increased local levels of the free form of IGF-1 may promote proliferation in the breast epithelium. This could be important in sex steroid dependent breast cancer development.Keywords
This publication has 27 references indexed in Scilit:
- Free insulin‐like growth factor‐I and breast cancer riskInternational Journal of Cancer, 2001
- Insulin-Like Growth Factor-I in Relation to Premenopausal Ductal Carcinoma in Situ of the BreastEpidemiology, 1998
- Circulating concentrations of insulin-like growth factor I and risk of breast cancerThe Lancet, 1998
- Endocrine effects of IGF-I on normal and transformed breast epithelial cells: potential relevance to strategies for breast cancer treatment and preventionBreast Cancer Research and Treatment, 1998
- Structure and function of the insulin-like growth factor I receptorBreast Cancer Research and Treatment, 1998
- Breast cancer and hormone replacement therapy: collaborative reanalysis of data from 51 epidemiological studies of 52 705 women with breast cancer and 108 411 women without breast cancerThe Lancet, 1997
- Insulin-like Growth Factor Binding Protein-3 Induces Apoptosis in MCF7 Breast Cancer CellsBiochemical and Biophysical Research Communications, 1997
- Insulin-like growth factor binding proteins and their role in controlling IGF actionsCytokine & Growth Factor Reviews, 1997
- Breast cancer risk associated with gynecologic surgery and indications for such surgeryInternational Journal of Cancer, 1997
- Breast cancer: cause and preventionThe Lancet, 1995